X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PFIZER - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PFIZER SANOFI INDIA/
PFIZER
 
P/E (TTM) x 32.5 28.5 114.0% View Chart
P/BV x 6.2 4.5 136.6% View Chart
Dividend Yield % 1.5 0.7 203.9%  

Financials

 SANOFI INDIA   PFIZER
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
PFIZER
Mar-16
SANOFI INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs4,5602,724 167.4%   
Low Rs4,4001,611 273.1%   
Sales per share (Unadj.) Rs1,028.5440.9 233.3%  
Earnings per share (Unadj.) Rs129.048.7 264.8%  
Cash flow per share (Unadj.) Rs186.075.8 245.4%  
Dividends per share (Unadj.) Rs68.0015.00 453.3%  
Dividend yield (eoy) %1.50.7 219.3%  
Book value per share (Unadj.) Rs753.6462.9 162.8%  
Shares outstanding (eoy) m23.0345.75 50.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.44.9 88.6%   
Avg P/E ratio x34.744.5 78.0%  
P/CF ratio (eoy) x24.128.6 84.2%  
Price / Book Value ratio x5.94.7 127.0%  
Dividend payout %52.730.8 171.2%   
Avg Mkt Cap Rs m103,17499,163 104.0%   
No. of employees `0003.62.9 125.4%   
Total wages/salary Rs m3,5922,758 130.3%   
Avg. sales/employee Rs Th6,537.76,981.7 93.6%   
Avg. wages/employee Rs Th991.4954.5 103.9%   
Avg. net profit/employee Rs Th819.8771.1 106.3%   
INCOME DATA
Net Sales Rs m23,68620,170 117.4%  
Other income Rs m708857 82.6%   
Total revenues Rs m24,39421,028 116.0%   
Gross profit Rs m5,2814,310 122.5%  
Depreciation Rs m1,3131,239 106.0%   
Interest Rs m155 288.5%   
Profit before tax Rs m4,6613,923 118.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m1,6911,794 94.2%   
Profit after tax Rs m2,9702,228 133.3%  
Gross profit margin %22.321.4 104.3%  
Effective tax rate %36.345.7 79.3%   
Net profit margin %12.511.0 113.5%  
BALANCE SHEET DATA
Current assets Rs m15,67316,299 96.2%   
Current liabilities Rs m6,6787,594 87.9%   
Net working cap to sales %38.043.2 88.0%  
Current ratio x2.32.1 109.3%  
Inventory Days Days7665 116.4%  
Debtors Days Days2226 86.7%  
Net fixed assets Rs m8,0988,622 93.9%   
Share capital Rs m230458 50.3%   
"Free" reserves Rs m17,08820,722 82.5%   
Net worth Rs m17,35621,180 81.9%   
Long term debt Rs m025 0.0%   
Total assets Rs m25,40029,137 87.2%  
Interest coverage x311.7755.5 41.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.7 134.7%   
Return on assets %11.87.7 153.3%  
Return on equity %17.110.5 162.7%  
Return on capital %26.919.0 141.9%  
Exports to sales %24.50.1 41,166.1%   
Imports to sales %28.017.5 160.1%   
Exports (fob) Rs m5,80112 48,341.7%   
Imports (cif) Rs m6,6273,526 188.0%   
Fx inflow Rs m7,14552 13,833.5%   
Fx outflow Rs m6,846140 4,890.7%   
Net fx Rs m299-88 -338.5%   
CASH FLOW
From Operations Rs m3,2263,436 93.9%  
From Investments Rs m-1,555-6,991 22.2%  
From Financial Activity Rs m-1,818-619 293.8%  
Net Cashflow Rs m-147-4,174 3.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 63.9 94.5%  
Indian inst/Mut Fund % 14.4 7.5 192.0%  
FIIs % 14.6 4.9 298.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 23.7 44.3%  
Shareholders   15,184 85,207 17.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   PIRAMAL ENTERPRISES  ABBOTT INDIA  PLETHICO PHARMA  MERCK LTD  GSK PHARMA  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jan 18, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS